A drug container includes a container body formed of a thermoplastic resin containing a cyclic polyolefin as a main component. The thermoplastic resin contains, as a lubricant, at least one compound selected from among a metal soap compound, an organic fatty acid ester compound, a synthetic wax compound, and a fatty acid amide compound. The lubricant content of the thermoplastic resin is 0.3 to 2.0 μg/g.